Home | Ge-Bu

Medication-induced liver injury: not just by paracetamol

Sander C.A. van den Bogert
Nr 11-12|2019 (53)|Main article|doi: 10.35351/gebu.2019.11-12.21

In view of the vital role played by the liver in drug metabolism, it is surprising how often this proceeds without any damage. Nevertheless it is clinically relevant for doctors and pharmacists to ...

In short Read article

Antidepressants as medication for insomnia?

Marielle A.E. Nieuwhof, Hein J.E.M. Janssens
Nr 11-12|2019 (53)|New|doi: 10.35351/gebu.2019.11-12.20

Despite evidence of its lack of effectiveness, the antidepressant mirtazapine is being used as a treatment option for insomnia, as has previously been discussed in Ge-Bu. Insofar as they have been ...

In short Read article

Visible and invisible influence of the medical devices industry in hospitals

Sanne van der Heijden
Nr 10|2019 (53)|Page 97-100|New|doi: 10.35351/gebu.2019.10.19

It is well-known that technicians employed by commercial companies are involved in the maintenance of working on medical devices in hospitals. Unclear, however, is what exactly they do, what their ...

In short Read article

Is an insulin pump not superior to injections for children with newly discovered diab

Tjalling W. de Vries
Nr 10|2019 (53)|Page 93-96|New|doi: 10.35351/gebu.2019.10.18

There is currently a trend to start the treatment of children with type 1 diabetes mellitus with a subcutaneous insulin pump, rather than with the conventional insulin injections. No clear evidenc ...

In short Read article

New product form: Calcipotriol/betamethasone aerosol foam for psoriasis

Leo M.L. Stolk
Nr 9|2019 (53)|Page 86-90|New|doi: 10.35351/gebu.2019.9.17

Calcipotriol/betamethasone aerosol foam 0.05mg/g and 0.5 mg/g (Enstilar®) were registered in 2016 for the ‘local treatment of psoriasis vulgaris in adults’. The combination of calcipotriol and bet ...

In short Read article

Treatment of actinic keratosis with 5-FU cream

Anton J.F.A. Kerst, Hein J.E.M. Janssens
Nr 9|2019 (53)|Page 81-85|New|doi: 10.35351/gebu.2019.9.16

Actinic keratosis is a skin disorder which occurs in about 30% of persons aged over 50 years (more commonly among men). The main causative factor is exposure to sunlight. If not treated, there is ...

In short Read article

PrEP effectively reduces risk of HIV infection, provided it is used with care

Sanne van der Heijden
Nr 8|2019 (53)|Page 74-78|Main article|doi: 10.35351/gebu.2019.8.15

The Dutch Minister for Medical Care and Sports has recently announced that the financial resources for care associated with so-called pre-exposure prophylaxis (PrEP) will be allocated to Dutch reg ...

In short Read article

Opioids for chronic pain: scarcely any added value

Anton J.F.A. Kerst. Hein J.E.M. Janssens
Nr 8|2019 (53)|Page 69-73|Main article|doi: 10.35351/gebu.2019.8.14

The unmistakable increase in the number of prescriptions for opioids (with their associated risks of addiction and adverse effects) should be a subject for debate. There is, or at least appears to ...

In short Read article

Search

Recent articles

Medication-induced liver injury: not just by paracetamol

Antidepressants as medication for insomnia?

Visible and invisible influence of the medical devices industry in hospitals

Is an insulin pump not superior to injections for children with newly discovered diab

New product form: Calcipotriol/betamethasone aerosol foam for psoriasis

Treatment of actinic keratosis with 5-FU cream

PrEP effectively reduces risk of HIV infection, provided it is used with care

Opioids for chronic pain: scarcely any added value